Rare victory in fight against melanoma.
- Published in:
- Nature, 2010, v. 467, n. 7312, p. 140, doi. 10.1038/467140b
- By:
- Publication type:
- Article
Works matching DE "PLEXXIKON Inc."
Results: 10
1
2
BRAF Inhibitors: Research Accelerates in Wake of Positive Findings.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2010, v. 102, n. 4, p. 214, doi. 10.1093/jnci/djq037
- By:
- Publication type:
- Article
3
Trial Offers Early Test Case for Personalized Medicine.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2009, v. 101, n. 3, p. 136, doi. 10.1093/jncI/djn506
- By:
- Publication type:
- Article
4
Targeting mutant BRAF and KIT in metastatic melanoma: ASCO 2009 meeting report.
- Published in:
- 2009
- By:
- Publication type:
- Report
5
Companies compete over mutation-specific melanoma drugs.
- Published in:
- Nature Medicine, 2011, v. 17, n. 3, p. 268, doi. 10.1038/nm0311-268a
- By:
- Publication type:
- Article
6
Road rules for drugs: a survey of signals.
- Published in:
- Nature Medicine, 2010, v. 16, n. 12, p. 1362, doi. 10.1038/nm1210-1362
- Publication type:
- Article
7
Finding the Perfect Fit.
- Published in:
- Bio-IT World, 2004, v. 3, n. 4, p. 36
- By:
- Publication type:
- Article
8
Dual fronts poised to transform melanoma therapy.
- Published in:
- Nature Reviews Drug Discovery, 2011, v. 10, n. 5, p. 325, doi. 10.1038/nrd3441
- By:
- Publication type:
- Article
9
Can cancer clinical trials be fixed?
- Published in:
- Nature Biotechnology, 2011, v. 29, n. 1, p. 13, doi. 10.1038/nbt.1746
- By:
- Publication type:
- Article
10
The science-business tango.
- Published in:
- 2006
- By:
- Publication type:
- Interview